BRD-K10846167 (BRD-K10846167)
Overview
- pert_id
- BRD-K10846167
- Name
- BRD-K10846167
- Collection
- STRD
- MOA
- Unknown
- Target(s)
- Unknown
- Indication(s)
- Unknown
- Phase
- Unknown
- Canonical SMILES
- C(Nc1nc(nc2n(cnc12)-c1ccsc1)N1CCOCC1)c1nc2cc3ccccc3cc2[nH]1
- InChI key
- InChIKey=YKFITDVTDUOHEH-UHFFFAOYSA-N
- InChI string
- InChI=1S/C25H22N8OS/c1-2-4-17-12-20-19(11-16(17)3-1)28-21(29-20)13-26-23-22-24(33(15-27-22)18-5-10-35-14-18)31-25(30-23)32-6-8-34-9-7-32/h1-5,10-12,14-15H,6-9,13H2,(H,28,29)(H,26,30,31)
- Molecular formula
- C25H22N8OS
- Molecular weight
- 482.56
External links
- PubChem
- 45100444
- SEP-L1000
- BRD-K10846167
Predicted MOAs
| MOA | Probability |
|---|---|
| CDK inhibitor | 0.3446 |
| PI3K inhibitor | 0.2618 |
| Aurora kinase inhibitor | 0.2048 |
| dopamine receptor antagonist | 0.0287 |
| histamine receptor antagonist | 0.0229 |
| HSP inhibitor | 0.0160 |
| adrenergic receptor antagonist | 0.0135 |
| HDAC inhibitor | 0.0107 |
| mTOR inhibitor | 0.0100 |
| protein synthesis inhibitor | 0.0092 |
Chemical structure
